No Phase 1 Filed. Irisin Delivers Anyway.
The grey-market peptide stack prices irisin-pathway exposure without Phase 1 data; two studies this week show resistance training produces the same molecule with measurable clinical endpoints.
By Sora WhitlamHealth Desk, Senior CorrespondentSun, May 17